tradingkey.logo
tradingkey.logo
検索

Genfit SA

GNFT
ウォッチリストに追加
4.850USD
0.0000.00%
終値 07/02, 13:00ET15分遅れの株価
741.27M時価総額
--直近12ヶ月PER

詳細情報 Genfit SA 企業名

Genfit SA is a France-based biopharmaceutical company focused on the discovery and development of therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, particularly due to a lack of approved treatments. The Company provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The Company leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.

Genfit SAの企業情報

企業コードGNFT
会社名Genfit SA
上場日Dec 19, 2006
最高経営責任者「CEO」Prigent (Pascal)
従業員数180
証券種類Depository Receipt
決算期末Dec 19
本社所在地Parc Eurasante 885 avenue Eugene Avinee
都市LOOS
証券取引所NASDAQ OMX - NASDAQ BASIC
France
郵便番号59120
電話番号33320164000
ウェブサイトhttps://www.genfit.fr/
企業コードGNFT
上場日Dec 19, 2006
最高経営責任者「CEO」Prigent (Pascal)

Genfit SAの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jean-Francois Mouney
Mr. Jean-Francois Mouney
Chairman of the Board of Directors
Chairman of the Board of Directors
--
--
Ms. Florence Sejourne
Ms. Florence Sejourne
Director, Representative of Biotech Avenir SAS
Director, Representative of Biotech Avenir SAS
--
--
Prof. Laurent Lannoo
Prof. Laurent Lannoo
Corporate Secretary, Director of Legal Affairs
Corporate Secretary, Director of Legal Affairs
--
--
Dr. Dean W. Hum, Ph.D.
Dr. Dean W. Hum, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Catherine Larue, Ph.D.
Dr. Catherine Larue, Ph.D.
Independent Director
Independent Director
--
--
Mr. Pascal Prigent
Mr. Pascal Prigent
Chief Executive Officer
Chief Executive Officer
--
--
Mrs. Anne-Helene Monsellato
Mrs. Anne-Helene Monsellato
Independent Director
Independent Director
--
--
Ms. Katherine Bach Kalin
Ms. Katherine Bach Kalin
Independent Director
Independent Director
--
--
Mr. Eric Baclet
Mr. Eric Baclet
Independent Vice-Chairman of the Board of Directors
Independent Vice-Chairman of the Board of Directors
--
--
Mr. Jean-Christophe Marcoux
Mr. Jean-Christophe Marcoux
Chief Corporate Affairs Officer, Head of Investor Relations, Head of ESG
Chief Corporate Affairs Officer, Head of Investor Relations, Head of ESG
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jean-Francois Mouney
Mr. Jean-Francois Mouney
Chairman of the Board of Directors
Chairman of the Board of Directors
--
--
Ms. Florence Sejourne
Ms. Florence Sejourne
Director, Representative of Biotech Avenir SAS
Director, Representative of Biotech Avenir SAS
--
--
Prof. Laurent Lannoo
Prof. Laurent Lannoo
Corporate Secretary, Director of Legal Affairs
Corporate Secretary, Director of Legal Affairs
--
--
Dr. Dean W. Hum, Ph.D.
Dr. Dean W. Hum, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Catherine Larue, Ph.D.
Dr. Catherine Larue, Ph.D.
Independent Director
Independent Director
--
--
Mr. Pascal Prigent
Mr. Pascal Prigent
Chief Executive Officer
Chief Executive Officer
--
--

よくある質問

Genfit SAの上位5名の株主は誰ですか?

Genfit SAの上位5名の株主は以下のとおりです。Mr. Jean-Francois Mouney

Genfit SA(GNFT)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Genfit SAの株式を保有している機関は16社あり、保有株式の総市場価値は約22.36Kで、全体の0.04%を占めています。2025Q4と比較して、機関の持ち株は-215235.00増加しています。